Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy

Digestive Endoscopy　/　2022

Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course

Hepatol Res　51,P.239-244　/　2021

Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report.

Clin J Gastroenterol　14,P.251-257　/　2021

Hepatic Inflammatory Pseudotumor Mimicking Malignant Tumor With Rare Onset of Intra-abdominal Hemorrhage.

Anticancer Res　41,P.2727-2732　/　2021

Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor.

Anticancer Res　41,P.5249-5254　/　2021

Mac-2 binding protein and its glycan isomer: Where does it come from? Where is it going?

Hepatol Res　51,P.1026-1028　/　2021

Exosomal circCMTM3 promotes the pathogenesis of hepatocellular carcinoma via angiogenesis.

Hepatol Res　51,P.1100-1101　/　2021

Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.

Anticancer Res　41,P.5855-5861　/　2021

A female patient with GSD IXc developing multiple and recurrent hepatocellular carcinoma: a case report and literature review.

Hum Genome Var　8,P.45　/　2021

"Improved visibility of early gastric cancer using a combination of chromoendoscopy and Texture and Color Enhancement Imaging"

Gastrointest Endosc　S0016-5107(21)01930-1.　/　2021

Successful treatment of occult pancreatic melanoma using BRAF/MEK inhibitors.

J Dermatol　47,P.e126-e147　/　2020

Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and L-arginine after DNA analysis produced a definitive diagnosis

Clin J Gastroenterol　13,P.823-833　/　2020

Cytomegalovirus enterocolitis in a patient with refractory immune-related colitis.

Case Rep Gastroenterol　14,P.103-109　/　2020

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy

J Clin Exp Hematop　60,P.51-54　/　2020

Multiple Gastric Polyps Improved After Treatment for Ulcerative Colitis.

Inflamm Bowel Dis　26,P.e144-e145　/　2020

Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer

Intern Med　59,P.2499-2504　/　2020

Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging.

Anticancer Res　40,P.5823-5828　/　2020

Hepatocellular Carcinoma With Extensive Cancer-associated Thrombosis Successfully Treated With Liver Resection and Direct Oral Anticoagulant: A Case Report.

Anticancer Res　40,P.6465-6471　/　2020

Cholangiolocarcinoma With Multiple Recurrences Successfully Treated With Repeated Liver Resection and Radiofrequency Ablation.

Anticancer Res　40,P.7147-7153　/　2020

Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.

J Dermatol　46,P.e339-e341　/　2019

Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse?

Clin J Gastroenterol　12,P.598-302　/　2019

Advanced parametric imaging for evaluation of Crohn’s disease using dual-energy computed tomography enterography.

Radiol Case Rep　13,P.709-712　/　2022

Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model

Front. Virol　/　2022

Mac-2 Binding Protein Glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa

J Glob Health　/　2022

Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

J Hepatol　77,P.967-977　/　2022

Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy

Digestive Endoscopy　/　2022

Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

J Hepatol　/　2022

Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings

Clin Gastroenterol Hepatol　/　2022

Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation

J　Gastroenterol　/　2022

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.

J Hepatol.　S0168-8278(22)00020-4.　/　2022

Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay.

Hepatol Res　/　2022

Blocking neddylation elicits antiviral effect against hepatitis B virus replication.

Mol Biol Rep　49,P.403-412　/　2022

Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection.

Liver Int.　42,P.124-134　/　2022

Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.

Hepatol Res　52,P.235-246　/　2022

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.

Sci Rep.　12,P.1517　/　2022

Mac-2-Binding Protein Glycan Isomer Predicts All Malignancies Post-sustained Virological Response in Chronic Hepatitis C

Hepatol Commun　/　2022

Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study

United European Gastroenterol J　10,P.93-103　/　2022

Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity

Hepatol Res　52,P.105-119　/　2022

Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.

Clin Gastroenterol Hepatol　20,P.874-885.e4　/　2022

Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.

Hepatol Res　52,P.93-104　/　2022

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection.

PLoS One　16,P.e0261878　/　2021

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR.

Cancers (Basel).　13,P.3455　/　2021

The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.

Dig Dis　/　2021

A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.

PLoS One. 　16,P.e0257166　/　2021

Long-term outcomes after endoscopic resection for late elderly patients with early gastric cancer

Gastrointest Endosc　S0016-5107(21)01942-8.　/　2021

Treatment strategies for reducing early and late recurrence of colonic diverticular bleeding based on stigmata of recent hemorrhage: a large multicenter study

Gastrointest Endosc　S0016-5107(21)01937-4　/　2021

Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study

BMC Gastroenterol　21,P.489　/　2021

Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma

Hepatol Commun　2021 Nov 27. doi: 10.1002/hep4.1872.　/　2021

Clinical impact of gastrointestinal endoscopy on the early detection of pharyngeal squamous cell carcinoma: A retrospective cohort study

World J Gastrointest Endosc　13,P.491-501　/　2021

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B

microorganisms　9,P.2083　/　2021

Blood‐Based Biomarkers in Hepatitis B Virus‐Related　Hepatocellular Carcinoma, Including the Viral Genome and　Glycosylated Proteins

Int. J. Mol. Sci　22,P.11051　/　2021

All-atom molecular dynamics study of hepatitis B virus containing pregenome RNA in solution

J Chem Phys　155,P.145101　/　2021

Outcomes in high and low volume hospitals in patients with acute hematochezia in a cohort study

Sci Rep　11,P.20373　/　2021

Risk of pancreatitis following biliary stenting with/without endoscopic sphincterotomy: A randomized controlled trial.

Clin Gastroenterol Hepatol　S1542-3565(21)00872-7.　/　2021

Identifying Bleeding Etiologies by Endoscopy Affected Outcomes in 10,342 Cases With Hematochezia: CODE BLUE-J Study

Am J Gastroenterol　116,P.2222-2234　/　2021

A Genome-Wide Association Study Identifying SVEP1 Variant as a Predictor of Response to Tolvaptan for Cirrhotic Ascites.

Liver Int　41,P.2944-2953　/　2021

N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis.

Glycobiology　31,P.1268-1278　/　2021

Application of Fluorescent-Based Technology Detecting Protein-Protein Interactions to Monitor the Binding of Hepatitis B Virus X protein to DNA-damage-binding protein 1.

BPPB　18,P.67-77　/　2021

Co-continuous structural effect of size-controlled macro-porous glass membrane on extracellular vesicle collection for the analysis of miRNA.

Sci Rep　11,P.8672　/　2021

Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation.

J Hepatol　75,P.302-310　/　2021

Modifed albumin–bilirubin grade to predict eligibility for second line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients

Int J Clin Oncol　26,P.922-932　/　2021

Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation.

Nat Metab　3,P.196-210　/　2021

Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antivirals.

Hepatol Res　51,P.528-537　/　2021

Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.

Infect Dis. 　24,P.1410-1421　/　2021

Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy

Cancer Sci　112,P.1943-1954　/　2021

Analysis of Hepatitis B virus genotype D in Greenland suggests presence of novel subgenotype .

Front Microbiol　11,P.602296　/　2021

Usefulness of an artificial intelligence system for the detection of esophageal squamous cell carcinoma evaluated with videos simulating overlooking situation

Dig Endosc　33,P.1101-1109　/　2021

Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies.

PLoS One　16,P.e0245211　/　2021

Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients infected patients.

Sci Rep　11,P.960　/　2021

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.

Hepatol Int　15,P.71-81　/　2021

Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV

J Hepatol　74,P.1075-1086　/　2021

Ten-Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild-Type Isocitrate Dehydrogenase 1

Hepatology　73,P.1747-1763　/　2021

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants.

Clin Gastroenterol Hepatol　19,P.46-60.e8　/　2021

Impact of retroflexion in the right colon after repeated forward-view examinations.

JGH open　2,P.282-287　/　2018

Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver

Transplant Proc　50,P.3858-3862　/　2018

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.

Open Forum Infect Dis　5,P.ofy268　/　2018

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

Aliment Pharmacol Ther　48,P.1128-1137　/　2018

Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.

Oncol Lett　16,P.5275-5281　/　2018

Type I interferon signaling prevents hepatitis B virus-specific T cell responses by reducing antigen expression

J Virol　92,P.e01099　/　2018

Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8 + T Cell Responses

J Virol　92,P.e01099　/　2018

Screening of microRNAs for a repressor of hepatitis B virus replication

Oncotarget　9,P.29857-29868　/　2018

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

Hepatol Int　12,P.356-367　/　2018

Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment.

Cancer Lett　434,P.91-100　/　2018

Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer

Hepatol Res　48,P.1081-1091　/　2018

Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection

Hepatol Res　48,P.1172-1177　/　2018

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry

Cell Chem Biol　25,P.906-915. e7　/　2018

Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells

Mol Ther　26,P.1840-1854　/　2018

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

J Gastroenterol　53,P.1276-1284　/　2018

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma

Hepatol Res　48,P.872-881　/　2018

Gut dysbiosis associated with hepatitis C virus infection

Clin Infect Dis　67,P.869-877　/　2018

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

Hepatol Int　12,P.133-142　/　2018

Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.

CPT Pharmacometrics Syst Pharmacol　7,P.384-393　/　2018

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

Hepatol Res　48,P.549-555　/　2018

Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers

Hepatol Res　97,P.170-176　/　2018

High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues

J Gastroenterol　53,P.883-889　/　2018

Antiviral therapy for hepatitis B virus during second pregnancies

J Obstet Gynaecol Res　44,P.566-569　/　2018

Late relapse after a sustained virologic response at 24 weeks after treatment with daclatasvir and asunaprevir combination therapy for chronic hepatitis c virus genotype 1b infection with liver cirrhosis

Intern Med　57,P.951-956　/　2018

Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus

Hepatol Res　48,P.E203-E212　/　2018

Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy

Clin Microbiol Infect　24,P.306. e7-306. e13　/　2018

Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease

J Gastroenterol　53,P.438-448　/　2018

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

J Gastroenterol　53,P.247-257　/　2018

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

J Gastroenterol　53,P.119-128　/　2018

Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients

Hepatol Res　48,P.134-143　/　2018

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

Hepatol Int　14,P.1023-1033　/　2020

Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study.

BMC Gastroenterol　20,P.371　/　2020

Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance.

Cell Rep　33,P.108265　/　2020

Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA

Virus Res　290,P.198191　/　2020

Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture

Int. J. Mol. Sci　21,P.7251　/　2020

Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups.

Pancreatology　20,P.1421-1427　/　2020

Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus

Hepatol Res　50,P.1128-1140　/　2020

Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation.

Liver Int　40,P.2961-2971　/　2020

Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis

Dig Dis Sci.　66,P.1080-1089　/　2020

Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy

Liver Cancer　9,P.207-220　/　2020

The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism

Liver Research　9,P.94-100　/　2020

"Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma"

J Hepatol　73,P.285-293　/　2020

Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity

Anal Biochem　597,P.113642　/　2020

Melinjo seed extract increases adiponectin multimerization in physiological and pathological conditions.

Sci Rep　10,P.4313　/　2020

Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis.

Cancer Lett　481,P.63-75　/　2020

The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world:

Hepatol Int　14,P.225-238　/　2020

A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population.

Diabetes Metab Syndr Obes　13,P.333-341　/　2020

7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety

Antiviral Res　176,P.104744　/　2020

JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.

J Gastroenterol　55,P.640-652　/　2020

Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling.

Hepatol Commun　4,P.255-267　/　2020

Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.

J Gastroenterol Hepatol　35,P.1420-1425　/　2020

MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.

Cancer Sci　111,P.869-880　/　2020

Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.

Carcinogenesis　41,P.1145-1157　/　2020

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

Clin Infect Dis　71,P.2840-2848　/　2020

Comparison of a 22-gauge Franseen-tip needle with a 20-gauge forward-bevel needle for the diagnosis of type 1 autoimmune pancreatitis: a prospective, randomized, controlled, multicenter study (COMPAS study).

Gastrointest Endosc　91,P.373-381.e2.　/　2020

Tenofovir versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

Am J Gastroenterol　115,P.271-280　/　2020

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.

Hepatology　71,P.1910-1922　/　2020

Real-world experience of 12-week DAA regimen of glecaprevir and pibrentasvir in patients with chronic HCV infection.

J Gastroenterol Hepatol　35,P.855-861　/　2020

Risk stratification of advanced colorectal neoplasia after baseline colonoscopy: Cohort study of 17 Japanese community practices.

Dig Endosc　32,P.106-113　/　2020

Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett’s esophagus

J Gastroenterol Hepatol　35,P.211-217　/　2020

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.

PLoS One　14,P.e0224184　/　2019

Hepatitis B virus-related hepatocellular carcinoma in young adults Efficacy of nationwide selective vaccination.

Hepatol Res　50,P.182-189　/　2019

Factors associated with longitudinal changes in serum concentrations of Mac-2 binding protein: a prospective 3-year observational study

Nutr Metab Cardiovasc Dis　29,P.1337-1344　/　2019

Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway

J Hematol Oncol.　12,P.144-144　/　2019

The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection.

Sci Rep　9,P.13393　/　2019

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

Hepatol Int　13,P.587-598　/　2019

MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells

Cell Death Dis　10,P.553　/　2019

Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.

J Viral Hepat　26,P.1266-1275　/　2019

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia

Exp. Ther. Med　18,P.596-604　/　2019

Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.

Antiviral Res　169,P.104537　/　2019

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

Open Forum Infect Dis　6,P.ofz185　/　2019

Small Interfering RNA Screening for the Small GTPase Rab Proteins Identifies Rab5B as a Major Regulator of Hepatitis B Virus Production

J Virol　93,P.e00621　/　2019

Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma

Cancer Lett　449,P.87-98　/　2019

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

J Hepatol　71,P.473-485　/　2019

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection

Hepatol Commun　3,P.493-503　/　2019

Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization

Proc Natl Acad Sci U S A　116,P.8487-8492　/　2019

Clinical evaluation of a newly developed chemiluminescent enzyme immunoassay in Japan for hepatitis C virus core antigen.

Jpn J Infect Dis　72,P.285-291　/　2019

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.

Aliment Pharmacol Ther　49,P.1230-1241　/　2019

Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately. A

Ann Surg Oncol　26,P.1385-1393　/　2019

The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection.

Aliment Pharmacol Ther　49,P.1060-1070　/　2019

CMCDG, a novel nucleoside analog with favorable safety features, exerts potent activity against wild-type and entecavir-resistant hepatitis B virus

Antimicrob Agents Chemother　63,P.e02143　/　2019

Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all-oral direct acting antivirals in patients with chronic hepatitis C virus infection

Hepatol Res　49,P.512-520　/　2019

Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma

J Gastroenterol　54,P.427-436　/　2019

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk

Aliment Pharmacol Ther　49,P.107-115　/　2019

TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy

J Gastroenterol　54,P.339-346　/　2019

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Blood　133,P.137-146　/　2019

Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study

Hepatol Res　49,P.125-135　/　2019

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

J Gastroenterol　54,P.87-95　/　2019

Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study

J Gastroenterol Hepatol　34,P.364-369　/　2019

An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People

Hepatology　69,P.19-33　/　2019